Is it safe?
Can INSM take a bad year?
Insmed Incorporated holds $617M more cash than debt, and is burning $202M a quarter, about 1.4 years of cover.
$617M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 4.57
Altman Z-score · safe zone, above 3
- Cash runway
- 1.4 years
Cash runway · burning $202M a quarter at the current rate
Details›
- Total debtQ2 2026
- $544M
- Cash and short-term investments
- $1.16B
- Net cash
- $617M
- EBITDA, trailing twelve months
- −$830M
- Operating profit, trailing twelve months
- −$841M
- Debt / equity
- 0.72×
- Annualised volatilitytwo years of daily moves
- 56%
- Worst drawdown on file
- −65%
- Below its 52-week high
- −41%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Biotechnology
Ranks #140 of 145 by Smart Score